the pharmacology , in vitro mycologic activity , toxicity , and efficacy of ketoconazole were studied in a phase-ii evaluation by the national institutes of health and national institute of allergy and infectious disease mycoses study group .
C0009450
infectious disease
C0026946
mycoses